Billion-Dollar Health Startups

The WSJ’s Billion Dollar Startup Club has identified 73 private companies that have been valued at $1 billion or more by venture capitalists. Here are profiles of two members of the club. Explore the full list at wsj.com/billionclub.

Latest valuation: $1.1 billion

Total equity funding: $354 million

Location: Redwood City, Calif.

Founded: 2001

CEO: Andrew Thompson

In the future, tiny computer chips no bigger than grains of sand will be embedded in prescription pills that inform doctors when patients have taken their medications.

Read more

Crowdsourcing to beat lethal PSA

Scientists at Plant & Food Research are hoping that crowdsourcing knowledge will help them find the answer to the lethal kiwifruit disease PSA.

The scientists have shared the genome sequences of kiwifruit and PSA bacterium online for other scientists around the world to determine the underlying biology of the infection and identify breeding tools that can control the disease.

Read more

NZ-Japan research to unlock health benefits in food

The Ministry of Business, Innovation and Employment (MBIE) has announced three collaborative research projects with Japan, which will focus on functional foods. Functional foods are innovative food products or ingredients that provide added benefits to human health and wellbeing beyond basic nutrition.

“MBIE will invest $400,000 in each project over two financial years through the bilateral Strategic International Collaborative Research Programme,” says MBIE’s Science Investments General Manager, Dr Prue Williams.

Read more

Put social ‘good’ on agenda, firms told

Internationally renowned Kiwi entrepreneur and social responsibility advocate Derek Handley sees Tauranga as well placed to embrace an evolving new business model in which doing good is as important as doing well.

The key theme of Mr Handley’s presentation and his discussions in Tauranga was the growing global trend to try and build business models where the product or service models created a significant social impact. That represented an evolution of the older corporate social responsibility model of using a portion of business profit to do good in the community or elsewhere, he said.

Read more

Choice is key in GM debate

OPINION: Agriculture is once again at the forefront of the national conversation about Australia’s future prosperity. Having ridden the mining boom all the way to shore, sectors such as agriculture are being viewed as the next wave of economic growth.

Improved market access through free trade agreements will undoubtedly help drive demand for Australia’s high quality food and fibre, particularly among the booming middle class of Asia.

Read more

Innovation is key to economic growth and competitiveness and is the basis of long term economic prosperity – Professor Lloyd:

Innovation is key to economic growth and competitiveness and is the basis of long term economic prosperity. Innovation is a combination of information, imagination and initiative – and it grows best when industry and higher education collaborate.
Educating Professionals
Even though we’re less than 25 years old, the University of South Australia (UniSA) has created more than 2000 partnerships with industry, the professions and our own peers to foster innovation and entrepreneurship and to build opportunities for sustained economic prosperity.

Forest owners ask govt for ETS crisis meeting

 Forest owners are asking the government to call an urgent meeting of primary sector leaders and iwi to deal with the country’s greenhouse gas emissions blow-out.They say a lack of new forest planting and a looming harvest “bulge” has to be addressed.

“Forests planted since 1990 have contributed to the credit side of the country’s climate change ledger. As these forests are harvested, without any significant offset from new planting, they will increasingly throw the ledger into the red. New Zealand’s lack of real action on climate change will become a stark reality,” says FOA chief executive David Rhodes.

Read more

Biopharma innovators gain accelerator successes

Two innovative University of Auckland medical research graduates are semi-finalists in an international business start-up competition with their new biopharma company.

Last year they won their section of the U.S. hosted, global business plan contest, the Breast Cancer Start-up Challenge with their newly created biopharma company, Mesopharm Therapeutics.  This year they are among an elite group of semi-finalists in another global healthcare accelerator contest.

Read more